[Value of imprint in bone marrow morphological examination]. 2010

Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
Laboratory of Bone Marrow, Department of Hematology, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310009, China.

OBJECTIVE To explore the role of bone marrow (BM) imprint in the diagnosis of hematological diseases. METHODS Between January 2002 and June 2008, a total of 3024 cases with BM smears, imprints and sections conducted simultaneously were recruited. There were 1667 males and 1357 females with a median age of 55 years old (range: 7 to 92). The cellularity on imprint and smear was evaluated with the standard cellularity on BM section. With the integrative diagnosis (including all examinations and clinical outcomes) as the standard, the diagnostic accuracy of hematological diseases were compared between BM imprint, smear and section groups. Another 79 cases of lymphoma and 114 cases of plasma cell myeloma (PCM) were selected for a correlation analysis of tumor cell infiltration patterns. RESULTS BM imprint contained hematopoietic and non-hematopoietic regions and cells retained integrated structure. The cellularity evaluation by imprint was superior to smear overall. In BM imprint group, the diagnostic accuracy for hypersplenism (n = 130), metastatic carcinoma (n = 67), refractory anemia with excess blasts, myeloproliferative neoplasm (n = 174), and PCM (n = 94) were better than smear group (96.9% vs 80.7%, 91.0% vs 76.1%, 92.6% vs 81.5%, 92.5% vs 76.4%, and 97.8% vs 92.6% respectively, all P < 0.05); And the diagnostic accuracy for megaloblastic anemia (n = 69), acute myeloid leukemia (n = 104), refractory cytopenia with unilineage dysplasia (n = 15), refractory cytopenia with multilineage dysplasia (n = 22), and lymphoplasmacytic lymphoma (n = 12) were higher than biopsy section group (100% vs 84.0%, 91.3% vs 74.0%, 86.7% vs 60.0%, 90. 9% vs 72.7%, and 66.6% vs 50.0% respectively, all P < 0.05); And the diagnostic accuracy for myelodysplastic/myeloproliferative neoplasm (n = 26) was higher than smear group (76.3%, P < 0.05) and biopsy section group (78.2%, P < 0.05). Excellent correlations existed between BM imprint and section of the patients with lymphoma or with PCM (r = 0.90, r = 0.78, both P < 0.05). CONCLUSIONS BM imprint contains the characteristics of both smear and section. BM imprint is superior to smear for an evaluation of cellularity. And it is also better than section for an analysis of cytological changes.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001856 Bone Marrow Examination Removal of bone marrow and evaluation of its histologic picture. Examination, Bone Marrow,Bone Marrow Examinations,Examinations, Bone Marrow
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D006402 Hematologic Diseases Disorders of the blood and blood forming tissues. Blood Diseases,Hematological Diseases,Blood Disease,Disease, Blood,Disease, Hematologic,Disease, Hematological,Diseases, Blood,Diseases, Hematologic,Diseases, Hematological,Hematologic Disease,Hematological Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
November 2014, Journal of clinical and diagnostic research : JCDR,
Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
December 1979, Medicina clinica,
Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
July 1980, Cancer,
Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
September 1957, Medical times,
Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
February 2002, Saudi medical journal,
Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
November 1985, American journal of clinical pathology,
Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
January 1950, Bulletin - Dade County Medical Association,
Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
May 2006, Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
March 1966, JAMA,
Xu-Bo Gong, and Xing-Guo Lu, and Gen-Bo Xu, and Xian-Guo Wu, and Lin Wang, and Xiao-Hong Zhang, and Lei Zhu, and Wei-Qin Wang
April 2002, Zhongguo shi yan xue ye xue za zhi,
Copied contents to your clipboard!